FCRL regulation in innate-like B cells

Annals of the New York Academy of Sciences

Volumn 1362, Issue 1, 2015, Pages 110-116

  Davis, Randall S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

B cells; BCR signaling; Kinase; Phosphatase; Regulation

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR RECEPTOR; B LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; FC RECEPTOR; FREB PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; B 1B CELL; B LYMPHOCYTE; BORRELIA HERMSII; BORRELIA INFECTION; CELL EXPANSION; CELL FUNCTION; CONTROLLED STUDY; HOMEOSTASIS; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; ANIMAL; HUMAN; INNATE IMMUNITY; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTE SUBSETS; HUMANS; IMMUNITY, INNATE; RECEPTORS, FC;

EID: 84959562205     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12771     Document Type: Article

References (53)

1. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
2. Shaw, P.X. et al. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
3. Hardy, R.R. & K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
4. Choi, Y.S. et al. 2012. B-1 cells in the bone marrow are a significant source of natural IgM. Eur. J. Immunol. 42: 120-129.
5. Kawahara, T. et al. 2003. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J. Immunol. 171: 5406-5414.
6. Haas, K.M. et al. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
7. Alugupalli, K.R. et al. 2004. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21: 379-390.
8. Martin, F. & J.F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
9. Pillai, S., A. Cariappa & S.T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
10. Martin, F. & J.F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175: 70-79.
11. Pillai, S. & A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9: 767-777.
12. Li, X. et al. 2001. Antigen receptor proximal signaling in splenic B-2 cell subsets. J. Immunol. 166: 3122-3129.
13. Oliver, A.M. et al. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27: 2366-2374.
14. Chumley, M.J., J.M. Dal Porto & J.C. Cambier. 2002. The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J. Immunol. 169: 1735-1743.
15. Holodick, N.E. & T.L. Rothstein. 2013. Atypical response of B-1 cells to BCR ligation: a speculative model. Front. Immunol. 4: 457.
16. Morris, D.L. & T.L. Rothstein. 1993. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177: 857-861.
17. Holodick, N.E., J.R. Tumang & T.L. Rothstein. 2009. Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. Mol. Immuno. 46: 3029-3036.
18. Hardy, R.R. 2006. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr. Opin. Immunol. 18: 547-555.
19. Davis, R.S. 2007. Fc receptor-like molecules. Annu. Rev. Immunol. 25: 525-560.
20. Akula, S., S. Mohammadamin & L. Hellman. 2014. Fc receptors for immunoglobulins and their appearance during vertebrate evolution. PLoS One 9: e96903.
21. Fayngerts, S.A., A.M. Najakshin & A.V. Taranin. 2007. Species-specific evolution of the FcR family in endothermic vertebrates. Immunogenetics 59: 493-506.
22. Li, F.J. et al. 2014. Emerging roles for the FCRL family members in lymphocyte biology and disease. Curr. Top. Microbiol. Immunol. 382: 29-50.
23. Wilson, T.J., A. Fuchs & M. Colonna. 2012. Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J. Immunol. 188: 4741-4745.
24. Franco, A. et al. 2013. Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors. J. Immunol. 190: 5739-5746.
25. Schreeder, D.M. et al. 2010. Cutting edge: FcR-like 6 is an MHC class II receptor. J. Immunol. 185: 23-27.
26. Campbell, J.A. et al. 2010. Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J. Immunol. 185: 28-32.
27. Campbell, J.A. et al. 2007. Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J. Exp. Med. 204: 1311-1317.
28. Ehrhardt, G.R. & M.D. Cooper. 2011. Immunoregulatory roles for fc receptor-like molecules. Curr. Top. Microbiol. Immunol. 350: 89-104.
29. Leu, C.M. et al. 2005. FcRH1: an activation coreceptor on human B cells. Blood 105: 1121-1126.
30. Haga, C.L. et al. 2007. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc. Natl. Acad. Sci. U.S.A. 104: 9770-9775.
31. Jackson, T.A. et al. 2010. FcR-like 2 inhibition of B cell receptor-mediated activation of B cells. J. Immunol. 185: 7405-7412.
32. Ehrhardt, G.R. et al. 2003. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. U.S.A. 100: 13489-13494.
33. Kochi, Y. et al. 2009. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J. Immunol. 183: 5502-5510.
34. Davis, R.S. et al. 2004. Differential B cell expression of mouse Fc receptor homologs. Int. Immunol. 16: 1343-1353.
35. Li, F.J. et al. 2013. FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation. Eur. J. Immunol. 43: 2980-2992.
36. Weller, S. et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
37. Won, W.J. et al. 2006. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J. Immunol. 177: 6815-6823.
38. Won, W.J. & J.F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168: 5605-5611.
39. Roark, J.H. et al. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160: 3121-3127.
40. Won, W.J., M.F. Bachmann & J.F. Kearney. 2008. CD36 is differentially expressed on B cell subsets during development and in responses to antigen. J. Immunol. 180: 230-237.
41. Zhu, Z. et al. 2013. FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 110: E1282-E1290.
42. Okazaki, T. et al. 2001. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. U.S.A. 98: 13866-13871.
43. Cornall, R.J. et al. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8: 497-508.
44. Hibbs, M.L. et al. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
45. Cyster, J.G. & C.C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2: 13-24.
46. Nishizumi, H. et al. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560.
47. Chan, V.W. et al. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69-81.
48. Shultz, L.D. et al. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445-1454.
49. Ono, M. et al. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383: 263-266.
50. Poe, J.C. et al. 2000. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J. Biol. Chem. 275: 17420-17427.
51. Adachi, T. et al. 1998. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J. Immunol. 160: 4662-4665.
52. Sen, G. et al. 1999. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J. Immunol. 29: 3319-3328.
53. Sohn, H.W. et al. 2011. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 118: 6332-6341.